MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
TherapeuticsMD ROE Ratio 2011-2026 | TXMD
Annual ROE Ratio TherapeuticsMD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -35.09 | 318.69 | 184.16 | 148.0 | -1914.39 | -135.98 | -59.21 | -70.5 | -134.91 | -112.04 | -51.96 | 2450.6 | 754.35 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2450.6 | -1914.39 | 103.21 |
Quarterly ROE Ratio TherapeuticsMD
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.12 | -4.92 | -10.88 | -8.75 | -20.79 | -30.58 | -34.38 | -31.03 | 28.97 | 101.02 | -322.0 | -335.88 | -289.99 | -267.33 | 250.34 | 630.99 | 619.05 | 562.67 | 517.68 | 148.0 | -423.22 | -796.94 | -1439.19 | -1914.39 | -1417.51 | -1106.59 | -540.32 | -135.98 | -112.09 | -86.87 | -67.95 | -59.21 | -60.63 | -68.97 | -70.37 | -70.5 | -80.31 | -91.56 | -118.19 | -134.91 | -140.88 | -146.85 | -126.2 | -112.04 | -78.37 | -41.53 | -19.02 | -0.05 | 0.36 | 0.67 | 1.51 | 2.45 | 88.9 | 175.46 | 236.92 | 194.38 | 86.85 | 62.29 | 45.24 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 630.99 | -1914.39 | -119.75 |
ROE Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
-43.6 | - | - | $ 142 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3276.74 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
431.6 | - | - | $ 754 M | USA |
 |
Canopy Growth Corporation
CGC
|
-122.76 | $ 1.2 | 1.27 % | $ 129 M |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
-162.53 | - | 7.5 % | $ 6.35 M | USA |
 |
Cronos Group
CRON
|
-4.28 | $ 2.68 | -0.56 % | $ 1.42 B | Canada |
 |
Agile Therapeutics
AGRX
|
88.64 | - | 10.11 % | $ 58.2 M | USA |
 |
Catalent
CTLT
|
-28.94 | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
-186.86 | - | - | $ 50.1 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-50.54 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
Eagle Pharmaceuticals
EGRX
|
15.26 | - | -39.89 % | $ 27.7 M | USA |
 |
HEXO Corp.
HEXO
|
-98.17 | - | 2.45 % | $ 38.1 M | Canada |
 |
Endo International plc
ENDP
|
37.13 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
302.08 | - | - | $ 36.6 M | USA |
 |
Emergent BioSolutions
EBS
|
-117.13 | $ 13.92 | 5.86 % | $ 713 M | USA |
 |
OrganiGram Holdings
OGI
|
-45.46 | $ 1.69 | 0.9 % | $ 402 M | Canada |
 |
Athenex
ATNX
|
1589.72 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-66.13 | $ 21.48 | -0.12 % | $ 2.04 B |  France |
 |
Evolus
EOLS
|
-913.07 | $ 5.72 | -3.3 % | $ 355 M | USA |
 |
Harrow Health
HROW
|
-34.5 | $ 50.79 | -5.07 % | $ 1.66 B | USA |
 |
China Pharma Holdings
CPHI
|
-61.13 | $ 1.38 | 9.13 % | $ 24.1 M |  China |
 |
Sundial Growers
SNDL
|
-88.87 | $ 1.66 | -1.19 % | $ 3.37 M | Canada |
 |
Jupiter Wellness
JUPW
|
2273.74 | - | - | $ 33.6 M | USA |
 |
Bausch Health Companies
BHC
|
57.93 | $ 7.9 | 3.41 % | $ 2.88 B | Canada |
 |
Lannett Company
LCI
|
92.26 | - | 1.15 % | $ 7.11 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-8.33 | $ 5.14 | 8.9 % | $ 72.3 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
7.34 | - | - | $ 193 M | Canada |
 |
Organogenesis Holdings
ORGO
|
0.33 | $ 4.32 | -0.92 % | $ 569 M | USA |
 |
Aurora Cannabis
ACB
|
-154.42 | $ 4.23 | -0.25 % | $ 86.3 M | Canada |
 |
Pacira BioSciences
PCRX
|
-12.79 | $ 26.13 | 3.24 % | $ 1.21 B | USA |
 |
PetIQ
PETQ
|
0.96 | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
-22.63 | - | -4.76 % | $ 65.3 M | USA |
 |
Perrigo Company plc
PRGO
|
-3.98 | $ 14.7 | -0.47 % | $ 2.02 B | USA |
 |
ProPhase Labs
PRPH
|
29.02 | - | - | $ 5.07 M | USA |
 |
Rockwell Medical
RMTI
|
-39.64 | $ 0.95 | 2.85 % | $ 22.2 M | USA |
 |
Radius Health
RDUS
|
27.81 | - | - | $ 1.42 B | USA |
 |
Relmada Therapeutics
RLMD
|
-115.74 | $ 4.3 | 5.39 % | $ 129 M | USA |
 |
OptiNose
OPTN
|
40.97 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
-240.53 | $ 9.35 | -1.86 % | $ 664 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-78.37 | $ 3.8 | - | $ 4.72 M | USA |
 |
PLx Pharma
PLXP
|
-129.32 | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
-90.86 | $ 5.58 | 1.64 % | $ 228 M | USA |
 |
SCYNEXIS
SCYX
|
91.88 | $ 0.64 | -0.12 % | $ 30.6 M | USA |
 |
Tricida
TCDA
|
-80993.58 | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
-43.81 | $ 8.95 | -3.35 % | $ 5.53 B | Canada |
 |
Veru
VERU
|
-116.97 | $ 2.34 | 0.43 % | $ 316 M | USA |
 |
Viatris
VTRS
|
9.86 | $ 12.42 | 0.12 % | $ 15.1 B | USA |
 |
cbdMD
YCBD
|
-7.78 | $ 1.11 | -3.91 % | $ 4.79 M | USA |
 |
Zomedica Corp.
ZOM
|
-14.39 | - | -0.21 % | $ 98 M | USA |